Data Foundry

Drug recalls 2026

Atorvastatin Calcium Tablets — Class II drug recall D-0113-2027

Ongoing recall by MSN Laboratories Private Limited (Formulations Division, Unit-II), reported 2026-11-04, distributed nationwide. Presence of Foreign Tablets/Capsules

Recall numberD-0113-2027
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmMSN Laboratories Private Limited (Formulations Division, Unit-II), Rangareddy District, India
Recall initiated2026-10-21
Classified2026-10-29
Reported by FDA2026-11-04
DistributedNationwide (US)
NDC72205-0022, 72205-0022-05, 72205-0022-30, 72205-0022-90, 72205-0022-99, 72205-0023, 72205-0023-05, 72205-0023-30, 72205-0023-90, 72205-0023-99, 72205-0024, 72205-0024-05, 72205-0024-30, 72205-0024-90, 72205-0024-99, 72205-0025, 72205-0025-05, 72205-0025-30, 72205-0025-90, 72205-0025-99
Lot numbersDRF09618A, DRG02110A
Expiration dates2029-08-31, 2030-01-31

Product

Atorvastatin Calcium Tablets, USP, 40mg, 1000 tablets per bottle, Rx only, Manufactured by: MSL Laboratories Private Limited, Telangana - 509228, India; Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854-3714. NDC: 72205-024-99

Reason for recall

Presence of Foreign Tablets/Capsules

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0113-2027. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-11-10. Not affiliated with or endorsed by FDA. Not medical or legal advice.